Inactive Instrument

Calendar MORPHOSYS Swiss Exchange

Equities

OXMOR

DE0006632003

Real-time Estimate Tradegate 20:28:31 16/05/2024 BST 5-day change 1st Jan Change
70.3 EUR 0.00% Intraday chart for MORPHOSYS 0.00% 0.00%

Chart calendar MORPHOSYS

816462f79cb8.qwFzex9LRSy40WqQtkAKsuVp4TelYmAm2umzE6WEjzg.mzkFKX0KFWOViBnI5x849J87t271IVBNjNHcau7pyhXycD9IQAAtdOvjJw~f12e6666b10fd4e900b610fdc182565d

Upcoming events on MORPHOSYS

31/05/2024 20:45 American Society of Clinical Oncology Annual Meeting - Abstract No #6502
31/05/2024 21:09 American Society of Clinical Oncology Annual Meeting - Abstract Number :6502
01/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No #3097
06/08/2024 Q2 2024 Earnings Call
06/08/2024 Q2 2024 Earnings Release After hours
29/10/2024 Q3 2024 Earnings Call
29/10/2024 Q3 2024 Earnings Release After hours
11/03/2025 Q4 2024 Earnings Release (Projected)
29/04/2025 Q1 2025 Earnings Release (Projected)
05/08/2025 Q2 2025 Earnings Release (Projected)
11/11/2025 Q3 2025 Earnings Release (Projected)

Past events on MORPHOSYS

29/04/2024 21:01 Q1 2024 Earnings Release
14/03/2024 12:00 Q4 2023 Earnings Call
13/03/2024 20:01 Q4 2023 Earnings Release
06/02/2024 13:00 Acquisition of MorphoSys AG by Novartis AG Call
10/01/2024 23:00 JPMorgan Healthcare Conference
11/12/2023 15:00 American Society of Hematology Meeting
11/12/2023 02:00 American Society of Hematology Meeting
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:3195
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:2813
11/12/2023 01:15 American Society of Hematology Meeting - Abstract Number #628
11/12/2023 00:30 American Society of Hematology Meeting - Abstract No:628
10/12/2023 01:30 American Society of Hematology Meeting - Abstract No:2415
09/12/2023 22:00 American Society of Hematology Meeting - Abstract No:265
05/12/2023 17:30 JMP Securities Hematology and Oncology Summit
21/11/2023 13:00 MANIFEST 2 Phase III Results Call
16/11/2023 13:00 Q3 2023 Earnings Call
15/11/2023 21:01 Q3 2023 Earnings Release
15/11/2023 12:30 Jefferies London Healthcare Conference
07/11/2023 Truist Securities Healthcare Conference
13/09/2023 19:55 Morgan Stanley Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
71,8
71,5
0.3%
328
327
0.23%
180
173
3.64%
278
249
11.77%
238
240
-0.63%

123

EBITDA
Million EUR
Released
Forecast
Spread
-102
-97,4
-4.36%
35,7
37,7
-5.31%
-268
-282
5.09%
-210
-242
13.27%
-242
-250
3.07%

-180

EBIT
Million EUR
Released
Forecast
Spread
-108
-98,9
-9.11%
27,4
37,0
-25.96%
-278
-290
4.15%
-221
-253
12.92%
-253
-258
1.96%

-385

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-107
-97,6
-9.13%
22,5
21,8
3.28%
-591
-267
-121.79%
-320
-480
33.43%
-191
-258
26.08%

-432

Net income
Million EUR
Released
Forecast
Spread
-103
-96,9
-6.28%
97,9
25,4
285.27%
-515
-253
-103.57%
-151
-473
68.06%
-190
-283
33.05%

-430

EPS
EUR
Released
Forecast
Spread
-3,26
-3,11
-4.88%
2,97
0,61
384.97%
-15,4
-7,94
-94.05%
-4,42
-13,4
66.95%
-5,53
-8,13
31.97%

-11,3

Announcement Date18/03/2015/03/2116/03/2215/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million EUR
Released
Forecast
Spread
270
263
2.65%
41,5
46,6
-10.94%
59,4
47,4
25.32%
95,8
64,0
49.6%
81,6
51,2
59.36%
62,3
42,3
47.45%
53,2
54,8
-2.86%
63,8
57,5
10.99%
59,0
59,4
-0.64%
64,7
55,4
16.84%

29,3


32,7


33,0


35,9

EBITDA
Million EUR
Released
Forecast
Spread
























-79,3
-102
22.36%















EBIT
Million EUR
Released
Forecast
Spread
163
171
-4.45%
-68,0
-16,0
-325%
-55,1
-60,9
9.53%
-29,3
-57,8
49.34%
-68,4
-133
48.63%
-69,5
-77,5
10.35%
-50,5
-70,8
28.65%
-51,0
-65,0
21.6%
-81,4
-82,3
1.09%
-382
-35,4
-981.21%

-40,8


-39,5


-40,0


-29,2

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread



-123
-18,0
-581.67%



-123
-58,9
-108.83%



-44,4


-74,0
-77,0
3.9%
-119
-70,0
-70.14%
46,7
-40,1
216.56%
-313
-36,5
-755.92%

-36,5


-46,5


-50,5




Net income
Million EUR
Released
Forecast
Spread
180
153
17.49%
-123
-14,0
-776.43%
-235
-78,6
-198.98%
-123
-49,0
-150.82%
329
194
69.82%
-44,4
-122
63.61%
-74,0
-75,9
2.51%
-120
-62,1
-92.69%
48,3
-76,1
163.46%
-315
-46,4
-578.56%

-49,1


-57,0


-61,2




EPS
EUR
Released
Forecast
Spread
5,54
4,78
15.9%
-3,59
-0,43
-734.88%
-6,88
-2,55
-169.8%
-3,60
-2,05
-75.61%
9,65
0,37
2484.84%
-1,30
-2,76
52.81%
-2,16
-2,35
8.09%
-3,50
-1,86
-88.34%
1,22
-2,42
150.31%
-8,37
-0,31
-2641.57%

-1,20


-1,08


-1,39


-0,66

Announcement Date05/08/2004/05/2203/08/2216/11/2215/03/2303/05/2309/08/2315/11/2313/03/2430/04/24----